Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07111416) titled 'Personalizing A1c Using Hematologic Indices and CGM for Accurate Diabetes Diagnosis' on Aug. 1.
Study Type: Observational
Primary Sponsor: Brigham and Women's Hospital
Condition:
Type 2 Diabetes
Recruitment Status: Not recruiting
Date of First Enrollment: September 1, 2025
Target Sample Size: 45
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07111416
Published by HT Digital Content Services with permission from Health Daily Digest....